CF patients
CF treatment
HIT-CF project
CF community
entire CF field
drug product candidates
Cystic Fibrosis Patients
Ultra-rare CFTR Mutations
Personalised Treatment
CFTR gene
label access
H2020 project
therapies
trial arm
specific trial
pharmaceutical partners
relevant global drug products
armed platform trial
pharmaceutical consortium partners
termed organoids
single compound
compound combination
personalised disease
prospective intestinal organoid test
label treatments of people
real paradigm shift
cultured intestinal miniature organs
new type of personalized medicine paradigm
therapy
gating
F508del
market approval
meta-analysis
patient groups
efficacy
response
future
individuals
effect
state-of-the-art methodology
reimbursement
crossover
innovative methodologies
therapeutic trials
rectal biopsies
placebo
individual level
laboratory
unique concept
major impacts
typical genotyping
goals